NCT04905654View on ClinicalTrials.gov

Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

May 16, 2023

Study Completion Date

May 16, 2023

Conditions
Headache, MigraineAura
Interventions
DRUG

Levcromakalim

To investigate the role of levcromakalim compared with placebo in migraine with aura patients

DRUG

Saline

To investigate the role of levcromakalim compared with placebo in migraine with aura patients

Trial Locations (1)

DK-2600

Danish Headache Center, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT04905654 - Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura | Biotech Hunter | Biotech Hunter